GENETICS This Company Wants to Rewrite the Future of Genetic Disease Megan Molteni | Wired “Tessera has spent the past two years developing a new class of molecular manipulators capable of doing lots of things CRISPR can do--and some that it can't, including precisely plugging in long stretches of DNA. It's not gene editing, says […]